Clinical trial
Arginine Feeding: a Novel Strategy to Improve Protein Metabolism in Cancer and…
NCT00497380 · Texas A&M University, Other · Completed
Key facts
| NCT number | NCT00497380 |
|---|---|
| Title | Arginine Feeding: a Novel Strategy to Improve Protein Metabolism in Cancer and the Response to Surgery |
| Official title | Arginine Feeding: a Novel Strategy to Improve Protein Metabolism in Cancer and the Response to Surgery |
| Lead sponsor | Texas A&M University, Other |
| Status | Completed |
| Study type | Interventional |
| Conditions | Protein Metabolism |
| Intervention type | Dietary Supplement |
| Interventions | Arginine |
| Enrollment | 19 |
| Start date | Aug 18, 2009 |
| Primary completion | Feb 4, 2012 |
| Completion | Feb 4, 2012 |
| First posted | Jul 6, 2007 |
| Last update posted | Sep 30, 2025 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: